30-04-2024, 12:00

Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab biosimilars
Globe Newswire30-04-2024, 12:00
22-04-2024, 12:00

Sandoz confirms European Commission approval of Pyzchiva® (ustekinumab), further strengthening immunology offering
Globe Newswire22-04-2024, 12:00
31-01-2024, 13:00

Sandoz launches first and only biosimilar for multiple sclerosis, Tyruko® (natalizumab), in Germany
Globe Newswire31-01-2024, 13:00
22-01-2024, 13:00

Sandoz announces agreement to acquire CIMERLI® business from Coherus, strengthening position in US market
Globe Newswire22-01-2024, 13:00
9-03-2023, 01:39

FFF Enterprises Inc. and RightNow Inventory™ Become Vital

Temecula, Calif., March 08, 2023 (GLOBE NEWSWIRE) -- FFF Enterprises Inc., the nation’s most trusted specialty drug
Globe Newswire9-03-2023, 01:39